Therapy of upper gastrointestinal tract cancers Journal Article


Authors: Atiq, O. T.; Kelsen, D.
Article Title: Therapy of upper gastrointestinal tract cancers
Abstract: Esophageal and gastric cancers are highly virulent tumors with an especially poor prognosis. They are rather common tumors in the United States with an anticipated annual incidence of approximately 32,000 new patients in 1991. Adenocarcinomas of the proximal stomach and lower esophagus are rapidly increasing in incidence; the reasons for this remain unclear. Endoscopic ultrasonography has offered a new dimension to staging especially of the primary tumor but also shows promise for more accurate identification of nodal metastasis. While stage remains the single most important prognostic variable, biological studies investigating tumor markers are a high priority; aneuploidy and HER-2/neu amplification or overexpression may predict poor outcome in gastric cancer. Esophageal and gastric cancers have a high local and distant failure rate when treated with conventional therapy. New developments in chemotherapy in the neoadjuvant and postoperative setting are under intense investigation in an attempt to improve prognosis for these diseases.
Keywords: combination chemotherapy; carcinoma; squamous-cell carcinoma; radiation-therapy; advanced gastric-cancer; southwest-oncology-group; epidermoid; phase-ii evaluation; methyl-ccnu; study-group trial; advanced esophageal-carcinoma
Journal Title: Current Problems in Cancer
Volume: 15
Issue: 5
ISSN: 0147-0272
Publisher: Mosby Elsevier  
Date Published: 1991-09-01
Start Page: 239
End Page: 294
Language: English
ACCESSION: WOS:A1991GN55300001
DOI: 10.1016/0147-0272(91)90018-6
PROVIDER: wos
PUBMED: 1743044
Notes: Review -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David P Kelsen
    537 Kelsen